Wockhardt LimitedNSE: WOCKPHARMA

Press Release Dec 11 2023

· Issued by Wockhardt Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-dec-11-2023-6

Wockhardt Limited has informed the Exchange regarding a press release dated December 11, 2023, titled "Wockhardt announces successful completion of pivotal Phase 3 pneumonia study of its macrolide antibiotic Nafithromycin WCK 4873.".

View Attachment

6ix hasn’t read this filing yet.

Wockhardt Limited on 6ix

Earlier from Wockhardt

Later from Wockhardt

All Wockhardt news releases